Inmed pharmaceuticals to participate in cowen's 4th annual cannabis conference

Vancouver, british columbia, nov. 23, 2021 (globe newswire) -- inmed pharmaceuticals inc. (“inmed” or the “company”) (nasdaq: inm), a leader in the development, manufacturing and commercialization of rare cannabinoids, today announced that inmed's management team is scheduled to participate in cowen's 4th annual cannabis conference to be held virtually on november 29 – december 1, 2021.
INM Ratings Summary
INM Quant Ranking